Andreas Pfützner

Part of Diakard, Inc., Pfützner Science & Health Institute GmbH is a healthcare company based in Mainz, Germany. The German company offers a comprehensive service for the conception and implementation of clinical studies, fulfilling the highest quality standards while considering the individual needs of their clients. The private company is led by Prof. Dr. Andreas Pfützner, a highly experienced physician and chemist with 18 years of clinical and pharmaceutical experience. Andreas Pfützner has been the CEO of the company since 2013. The company was acquired by Diakard, Inc. on January 05, 2021.

Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT.

Part of Eli Lilly & Co., Lilly Deutschland GmbH is a pharmaceutical company based in Bad Homburg, Germany. The German company manufactures pharmaceutical products. The private company was founded in 1960 by Eli Lilly. The CEO is Kadir Tepebasi.

Ikfe Institut für Klinische Forschung und Entwicklung GmbH is a research and development company based in Mainz, Germany. Ikfe engages in research and development in the field of natural sciences, engineering, agricultural sciences, and medicine. The German company was founded in 1998.